Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

LIPO-AMIC Technique Description: Autologous Matrix Induced-Chondrogenesis With Microfragmented Adipose Tissue Graft.

Debieux P., Ribeiro GG., Wong KL., Cohen M., Kaleka CC.

Laboratory Study on Cartilage Damage, published in Arthrosc Tech (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Arthrosc Tech (2024)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40207325
PMCID
PMC11977164
DOI
10.1016/j.eats.2024.103279
Citations
1

Abstract (original English)

Cartilage injuries have historically been challenging to manage, but recent advancements have rapidly expanded treatment options. The incorporation of mesenchymal stem cell sources, such as bone marrow or adipose tissue, has improved repair tissue quality and clinical outcomes. The LIPO-AMIC procedure for full-thickness knee cartilage lesions uses a collagen matrix combined with microfragmented adipose tissue grafts as a source of adipose-derived stem cells, leveraging their chondrogenic differentiation capacity and paracrine activity. This adaptation aims to enhance outcomes and provides a single-stage knee cartilage repair option with biological augmentation.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research